RALLIS CHRIS A (CIK 1185945) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-12). Recent activity: Buy FENC (14,344 shares), Sell FENC (8,346 shares), Buy FENC (4,062 shares), Sell FENC (1,775 shares), Buy FENC (2,127 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-12 | FENNEC PHARMACEUTICALS INC. (FENC) | Director | Buy | 14,344 | $34,999 |
| 2026-05-12 | FENNEC PHARMACEUTICALS INC. (FENC) | Director | Sell | 8,346 | $58,756 |
| 2025-10-14 | FENNEC PHARMACEUTICALS INC. (FENC) | Director | Buy | 4,062 | $4,996 |
| 2025-10-14 | FENNEC PHARMACEUTICALS INC. (FENC) | Director | Sell | 1,775 | $16,401 |
| 2025-07-07 | FENNEC PHARMACEUTICALS INC. (FENC) | Director | Buy | 2,127 | $4,998 |
| 2025-07-07 | FENNEC PHARMACEUTICALS INC. (FENC) | Director | Sell | 1,119 | $9,746 |
| 2025-04-11 | FENNEC PHARMACEUTICALS INC. (FENC) | Director | Buy | 2,173 | $4,998 |
| 2025-04-11 | FENNEC PHARMACEUTICALS INC. (FENC) | Director | Sell | 1,409 | $6,975 |
| 2025-02-14 | FENNEC PHARMACEUTICALS INC. (FENC) | Director | Buy | 1,992 | $5,000 |
| 2025-02-14 | FENNEC PHARMACEUTICALS INC. (FENC) | Director | Sell | 1,186 | $8,089 |
Source: SEC Form 4 filings · as of 2026-05-12